HomeNewsBusinessNHAI plans to award 1,000-1,500 km of projects under BOT model in 2023-24

NHAI plans to award 1,000-1,500 km of projects under BOT model in 2023-24

In the current financial year, NHAI had initially planned to award 600-1,000 km highway stretches through the BOT model and managed to award projects of around 650 km, an NHAI official said.

March 15, 2023 / 17:50 IST
Story continues below Advertisement

After seeing renewed interest from private players for build-operate-transfer (BOT) projects, the National Highways Authority of India (NHAI) is looking to come out with more tenders for around 1,500-2,000 km of roads in 2023-24, multiple government officials said.

"NHAI plans to offer around two highway upgradation projects to private players using the BOT model in every quarter in 2023-24," a government official said.

Story continues below Advertisement

He added that NHAI will also soon amend the bidding norms to attract more private participation in BOT projects.

"NHAI may look to provide a minimum toll revenue guarantee to make it easier for contractors to bid for BOT projects," the official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show